Apyx Medical (NASDAQ:APYX) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Apyx Medical (NASDAQ:APYX) released its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.05, Zacks reports. Apyx Medical had a negative return on equity of 158.22% and a negative net margin of 37.11%.The business had revenue of $12.88 million for the quarter, compared to the consensus estimate of $12.00 million. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Stock Performance

Shares of APYX stock traded up $0.52 during mid-day trading on Friday, hitting $3.87. 235,601 shares of the stock were exchanged, compared to its average volume of 110,221. The stock’s fifty day simple moving average is $2.59 and its two-hundred day simple moving average is $2.08. The stock has a market capitalization of $146.36 million, a price-to-earnings ratio of -8.60 and a beta of 1.60. The company has a debt-to-equity ratio of 4.61, a quick ratio of 3.95 and a current ratio of 4.72. Apyx Medical has a 12-month low of $0.76 and a 12-month high of $3.99.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Apyx Medical in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Institutional Investors Weigh In On Apyx Medical

Large investors have recently modified their holdings of the company. Osaic Holdings Inc. purchased a new position in shares of Apyx Medical during the second quarter worth approximately $50,000. Vanguard Group Inc. boosted its stake in Apyx Medical by 3.6% during the 3rd quarter. Vanguard Group Inc. now owns 1,528,947 shares of the company’s stock worth $3,272,000 after purchasing an additional 53,175 shares during the period. Finally, Nantahala Capital Management LLC grew its position in Apyx Medical by 2.5% during the 2nd quarter. Nantahala Capital Management LLC now owns 3,338,048 shares of the company’s stock worth $7,511,000 after purchasing an additional 80,000 shares during the last quarter. 55.33% of the stock is owned by institutional investors and hedge funds.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.